Lobe Sciences (LOBE) Ratios
Lobe Sciences Ratios
DE:LOBE's free cash flow for Q3 2026 was $-707.47K. For the 2026 fiscal year, DE:LOBE's free cash flow was increased by $0.00 and operating cash flow was $-707.47K. See a summary of the company’s cash flow.
| Ratios | Nov 25 | Nov 24 | Aug 23 | Nov 22 | Nov 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.13 | 0.11 | 0.13 | 0.80 | 12.02 |
| Quick Ratio | 3.13 | 0.11 | 0.12 | 0.80 | 12.02 |
| Cash Ratio | 2.41 | 0.10 | 0.06 | 0.70 | 1.42 |
| Solvency Ratio | -1.64 | -1.29 | -1.90 | -9.40 | -28.09 |
| Operating Cash Flow Ratio | -0.58 | -0.20 | -0.70 | -2.10 | -6.26 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -0.72 | -5.17 | 0.00 | 0.00 |
| Net Current Asset Value | $ 4.89M | $ -3.11M | $ -2.14M | $ -266.08K | $ 8.86M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 6.76 | 0.14 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.12 | -0.56 | -2.08 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.10 | -1.28 | 1.93 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.10 | -0.55 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 3.22 | -0.08 | -14.36 | 3.92 | 1.07 |
| Debt Service Coverage Ratio | -7.15 | -5.01 | -12.41 | 0.00 | 0.00 |
| Interest Coverage Ratio | -7.00 | -11.34 | -86.93 | 0.00 | 0.00 |
| Debt to Market Cap | 0.04 | 0.72 | 0.13 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 1.31 | -0.37 | -0.04 | 0.08 | 0.19 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 98.71% | 91.94% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | -3084.32% | -528.95% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | -3021.92% | -523.71% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | -1553.54% | -399.63% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | -3221.61% | -535.61% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | -3245.84% | -560.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | -3245.84% | -560.00% | 0.00% | 0.00% |
| Net Income Per EBT | 91.07% | 100.75% | 104.55% | 100.00% | 95.71% |
| EBT Per EBIT | 116.41% | 207.37% | 134.03% | 297.91% | 374.02% |
| Return on Assets (ROA) | -58.34% | -1709.79% | -204.70% | -701.09% | -188.64% |
| Return on Equity (ROE) | -187.94% | 141.95% | 2939.54% | -2749.22% | -202.08% |
| Return on Capital Employed (ROCE) | -80.88% | 105.33% | 2097.71% | -922.84% | -56.45% |
| Return on Invested Capital (ROIC) | -80.88% | 154.74% | -1947.10% | -922.84% | -54.03% |
| Return on Tangible Assets | -58.34% | -1709.79% | -1473.91% | -713.25% | -189.26% |
| Earnings Yield | -63.84% | -180.99% | -180.43% | -340.66% | -180.08% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 14.58 | 56.35 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.05 | 0.01 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 3.99 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.53 | 0.37 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | -0.07 | -0.70 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -162724.91 | -6581.34 | -42682.40 | 0.00 |
| Days of Sales Outstanding | 0.00 | 25.04 | 6.48 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 91.53 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 162749.95 | 6679.35 | 42682.40 | 0.00 |
| Operating Cycle | 0.00 | 25.04 | 98.01 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.00 | -0.02 | -0.07 | -0.16 |
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.02 | -0.07 | -0.16 |
| Dividend Paid and CapEx Coverage Ratio | -354281.00 | -154097.67 | -429661.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -354281.00 | -154097.67 | -429661.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -5.18 | -0.26 | -5.17 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | -3.39 | -2.04 | 0.00 | 0.00 |
| Free Cash Flow Yield | -20.43% | -18.93% | -65.88% | -75.92% | -39.75% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.57 | -0.55 | -0.55 | -0.29 | -0.56 |
| Price-to-Sales (P/S) Ratio | 0.00 | 17.93 | 3.10 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.94 | -0.78 | -16.29 | 8.07 | 1.12 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.89 | -5.28 | -1.52 | -1.32 | -2.52 |
| Price-to-Operating Cash Flow Ratio | -4.89 | -5.28 | -1.52 | -1.32 | -2.52 |
| Price-to-Earnings Growth (PEG) Ratio | 0.13 | 0.03 | 0.01 | 0.01 | -0.00 |
| Enterprise Value Multiple | -0.32 | -0.96 | -0.64 | -0.22 | -1.87 |
| Enterprise Value | 1.36M | 3.95M | 2.80M | 2.69M | 11.53M |
| EV to EBITDA | -0.32 | -0.96 | -0.64 | -0.22 | -1.87 |
| EV to Sales | 0.00 | 29.01 | 3.33 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.96 | -8.55 | -1.63 | -0.98 | -2.29 |
| EV to Operating Cash Flow | -0.96 | -8.55 | -1.63 | -0.98 | -2.29 |
| Tangible Book Value Per Share | 0.04 | -0.03 | -0.02 | 0.01 | 0.35 |
| Shareholders’ Equity Per Share | 0.02 | -0.03 | -0.00 | 0.01 | 0.35 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.01 | -0.05 | -1.11 | 0.04 |
| Revenue Per Share | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Net Income Per Share | -0.03 | -0.04 | -0.05 | -0.32 | -0.70 |
| Tax Burden | 0.91 | 1.01 | 1.05 | 1.00 | 0.96 |
| Interest Burden | 1.14 | 1.04 | 1.01 | 1.02 | 3.74 |
| Research & Development to Revenue | 0.00 | 2.84 | 1.48 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 12.99 | 3.09 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 2.00 | 0.36 | 0.00 | 0.00 |
| Income Quality | 0.32 | 0.10 | 0.37 | 0.22 | 0.22 |
Currency in CAD
